申请人:MERCK SHARP & DOHME
公开号:WO2021101836A1
公开(公告)日:2021-05-27
The present invention provides methods of treating malaria comprising administration of compounds of Formula (I) or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the variables are as defined herein. The invention also provides uses of the compounds of Formula (I), as defined herein, for the possible inhibition of plasmepsin X, plasmepsin IX or plasmepsin X and IX activity, for treating a Plasmodium infection, and for treating malaria. Also provided are methods of treatment further comprising administration of one or more additional anti-malarial compounds.
本发明提供了治疗疟疾的方法,包括向需要的受试者施用化合物I式或其药用可接受的盐,其中变量如本文所定义。该发明还提供了化合物I式的用途,如本文所定义,用于可能抑制血浆蛋白酶X、血浆蛋白酶IX或血浆蛋白酶X和IX活性,用于治疗疟原虫感染和治疗疟疾。还提供了治疗方法,进一步包括施用一种或多种额外的抗疟疾化合物。